Antibe Therapeutics Inc.
ATE
Rang în acțiuni
#31903
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Preț acțiune
$0.21483059
Ultima sincronizare: 2024-05-07
Capitalizare de piață
$11.13M
Schimbare (1 zi)
0.34%
Schimbare (1 an)
-0.36%
Țară
CA
Tranzacționează Antibe Therapeutics Inc. (ATE)
Categorie
Healthcare
Istoricul randamentului dividendelor pentru Antibe Therapeutics Inc. (ATE)
Randamentul dividendelor (TTM) pentru Antibe Therapeutics Inc. (simbol acțiune: ATE) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Antibe Therapeutics Inc. (ATE) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
| An | Randamentul dividendelor | Schimbă |
|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | ||
Randamentele dividendelor (TTM) pentru companii similare sau concurente
| Companie | Randamentul dividendelor | Țara |
|---|---|---|
| 2.45% |
US
|
|
| 3.69% |
IE
|
|
| 1.25% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
DE
|
